Updates on Navin Khanna, ICGEB Delhi and his killer work on Dengue


Navin Khanna heads the Recombinant Gene Products Group at ICGEB New Delhi; his work is featured in "The Ken",  this month, referring to him as "India's Judge Dredd of Dengue" (an allusion to Judge Joseph Dredd, British comic book law enforcement officer), and explains how in the 26 years that he has been at ICGEB he has developed 26 diagnostic kits, 23 of which are on the market.

In October 2016, ICGEB entered into a partnership with Sun Pharma to develop a novel dengue vaccine for India and Global markets, based on the work of Navin Khanna.


Further reading:

1 January 2017
The Ken: Meet India's Judge Dredd of Dengue

19 October 2016
ICGEB & Sun Pharma announce a new exclusive collaboration to develop novel dengue vaccine for India & Global markets

13 October 2016
Nature: ICGEB-Emory Vaccine Center Scientists unmask body's immune cells that fight dengue

7 May 2016
Sun Pharma and ICGEB New Delhi to develop botanical drug for dengue

22 September 2015
A dengue vaccine might be ready in five years

28 October 2014
ICGEB launches a diagnostic kit for Celiac Disease

20 September 2013
Indian scientist break dengue code

8 February 2012
Khanna awarded fror research on anti dengue vaccines

 

tl_files/News2014/Khanna.jpg

For further information please contact:

Suzanne KerbavcicHead, Communications & Outreach
ICGEB Trieste
Tel: +39-040-3757315
E-mail: press@icgeb.org

Go back

Cod. Fisc. 90031700322

AREA Science Park
Padriciano 99
34149 Trieste, ITALY
Tel: +39-040-37571
Fax: +39-040-226555
icgebicgeb.org
Address book

 

 

 

 

 

 

 

 tl_files/iTunes_Badge_Color_master_10251024.png

 

tl_files/FB.png tl_files/Twitter_logo_blue-1def.png tl_files/rss.png
tl_files/LinkedIn-InBug-2CRev2.png tl_files/YouTube.png